A carregar...

In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins

Prolonged remissions were induced in mice bearing advanced BCL1 tumors by the combined approach of nonspecific cytoreductive therapy and administration of a tumor-reactive immunotoxin. Thus, the vast majority of the tumor cells (approximately 95%) were first killed by nonspecific cytoreductive thera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Formato: Artigo
Idioma:Inglês
Publicado em: The Rockefeller University Press 1982
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2186702/
https://ncbi.nlm.nih.gov/pubmed/6804591
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!